Table 1 Clinical characteristic of patients infected with NTM isolates
From: Molecular epidemiology of nontuberculous mycobacteria isolated from tuberculosis-suspected patients
Factors | NTM positive patients (n = 62) | P-value |
|---|---|---|
Mean age ± SD | 53.2 ± 11.6 | 0.072 |
Gender | Â | 0.125 |
Male | 35 (56.5%) | Â |
Female | 27 (43.5%) | Â |
History of smoking | Â | 0.752 |
Smokers | 29 (46.8%) | Â |
Non-smokers | 32 (53.2%) | Â |
Symptoms | Â | 0.042* |
Cough | 49 (92.5%) | Â |
Sputum | 45 (84.9%) | Â |
Fever | 45 (84.9%) | Â |
Weight loss | 35 (66.1%) | Â |
Night perspiration | 32 (60.4%) | Â |
Gastroesophageal | 26 (49.1%) | Â |
Dyspnea | 18 (33.9%) | Â |
Hemoptysis | 12 (22.6%) | Â |
Underlying disease | Â | 0.052 |
Obesity | 14 (22.6%) | Â |
Gastrointestinal diseases | 10 (16.1%) | Â |
HIV | 8 (12.9%) | Â |
Cystic Fibrosis | 6 (9.8%) | Â |
Diabetes mellitus | 5 (8.1%) | Â |
Asthma | 4 (6.5%) | Â |
AFB smear microscopy | Â | 0.457 |
Positive | 38 (21.3%) | Â |
Negative | 24 (38.7%) | Â |
Radiographic findings | Â | 0.038* |
Bronchiectasis | 30 (48.4%) | Â |
Infiltrate | 22 (35.5%) | Â |
Cavitary | 15 (24.2%) | Â |
Consolidation | 13 (21.0%) | Â |
NTM isolates | Â | Â |
M. simiae | 18 (29.0%) | Â |
M. fortuitum | 13 (21.1%) | Â |
M. kansasii | 9 (14.5%) | Â |
M. marinum | 9 (14.5%) | Â |
M. chelonae | 6 (9.7%) | Â |
M. mucogenicum | 3 (4.8%) | Â |
M. canariasense | 2 (3.2%) | Â |
M. bacteremicum | 1 (1.6%) | Â |
M. jacuzzii | 1 (1.6%) | Â |